We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
+14.09%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+302.07%
AUM
$79.1B
AUM Growth
+$7.99B
(+11%)
Cap. Flow
-$5.86B
Cap. Flow
% of AUM
-7.4%
Top 10 Holdings %
Top 10 Hldgs %
22.63%
Holding
2,061
New
445
Increased
504
Reduced
465
Closed
231
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sysco
SYY
|
+$273M |
| 2 |
Waste Management
WM
|
+$168M |
| 3 |
Lowe's Companies
LOW
|
+$160M |
| 4 |
PNC Financial Services
PNC
|
+$154M |
| 5 |
Unilever
UL
|
+$122M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$548M |
| 2 |
Apple
AAPL
|
+$372M |
| 3 |
CSX Corp
CSX
|
+$369M |
| 4 |
Infosys
INFY
|
+$238M |
| 5 |
Kimberly-Clark
KMB
|
+$235M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.16% |
| 2 | Healthcare | 14.65% |
| 3 | Financials | 13.08% |
| 4 | Industrials | 9.66% |
| 5 | Consumer Discretionary | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Merck
MRK
$318B
| $147M | 0.19% |
1,882,216
-7,149
| -0.4% | -$547K |
|
102
UnitedHealth
UNH
$372B
| $145M | 0.18% |
412,937
-7,889
| -2% | -$2.64M |
|
|
NLSN
103
DELISTED
Nielsen Holdings plc
NLSN
| $142M | 0.18% |
6,814,422
+2,586,463
| +61% | +$42M |
|
104
Novartis
NVS
$291B
| $141M | 0.18% |
1,490,654
-374,806
| -20% | -$32.8M |
|
105
NetEase
NTES
$83.7B
| $140M | 0.18% |
1,465,690
-329,820
| -18% | -$29.6M |
|
106
Target
TGT
$67.5B
| $139M | 0.18% |
787,620
+13,896
| +2% | +$2.32M |
|
107
Cadence Design Systems
CDNS
$94.2B
| $135M | 0.17% |
990,215
-150,738
| -13% | -$17.7M |
|
108
H&R Block
HRB
$5.8B
| $131M | 0.17% |
8,272,674
+3,234,810
| +64% | +$55.9M |
|
|
CHL
109
DELISTED
China Mobile Limited
CHL
| $130M | 0.16% |
4,553,253
-5,946,769
| -57% | -$184M |
|
110
Omnicom Group
OMC
$22.4B
| $130M | 0.16% |
2,078,171
+816,725
| +65% | +$46.7M |
|
111
LKQ Corp
LKQ
$6.1B
| $124M | 0.16% |
3,522,926
+3,521,741
| +297,193% | +$120M |
|
112
Eli Lilly
LLY
$992B
| $124M | 0.16% |
735,000
-7,773
| -1% | -$1.16M |
|
113
Cognizant
CTSH
$25.1B
| $123M | 0.16% |
1,506,206
+450,026
| +43% | +$34.2M |
|
|
114
Pfizer
PFE
$145B
| $123M | 0.16% |
3,337,672
-14,953,399
| -82% | -$548M |
|
115
iShares Core MSCI Emerging Markets ETF
IEMG
$157B
| $122M | 0.15% |
1,962,426
-239,896
| -11% | -$13.8M |
|
116
Banco Bradesco
BBD
$37.9B
| $121M | 0.15% |
27,833,525
+2,897,666
| +12% | +$10.6M |
|
117
Comcast
CMCSA
$88B
| $121M | 0.15% |
2,302,510
+327,548
| +17% | +$15.7M |
|
118
Tapestry
TPR
$31.5B
| $120M | 0.15% |
3,876,124
+155,916
| +4% | +$3.95M |
|
119
Adobe
ADBE
$102B
| $120M | 0.15% |
239,936
-10,958
| -4% | -$5.29M |
|
120
Tesla
TSLA
$1.3T
| $115M | 0.15% |
490,287
+18,444
| +4% | +$3.15M |
|
121
Vanguard FTSE Emerging Markets ETF
VWO
$123B
| $113M | 0.14% |
2,252,478
-172,267
| -7% | -$8.09M |
|
122
NXP Semiconductors
NXPI
$60.2B
| $113M | 0.14% |
707,701
-5,375
| -0.8% | -$792K |
|
123
Prudential
PUK
$36.9B
| $111M | 0.14% |
3,106,334
-45,587
| -1% | -$1.4M |
|
124
Mastercard
MA
$500B
| $111M | 0.14% |
310,487
-127,257
| -29% | -$42.3M |
|
125
Eaton
ETN
$173B
| $109M | 0.14% |
905,233
+780,239
| +624% | +$88.2M |
|
Similar funds
QCM
Lazard Asset Management's Q4 2020 Portfolio in Review
As of Q4 2020, Lazard Asset Management held 2,061 positions worth $79.1B, up 11% from $71.1B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Lazard Asset Management withdrew a net $5.86B in Q4 2020, closing 231 positions and reducing 465 holdings. Its most notable exit was Unilever NV New York Registry Shares, an estimated $112M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Lazard Asset Management opened a new position in Sotera Health worth $100M.
- Lazard Asset Management's largest Q4 2020 buy was Sotera Health: 3,651,831 shares worth $100M.
- Lazard Asset Management added most to Sysco in Q4 2020, an estimated $273M increase.
- Lazard Asset Management's biggest Q4 2020 reduction was Pfizer, cutting an estimated $548M.
- Lazard Asset Management fully exited Unilever NV New York Registry Shares in Q4 2020, selling an estimated $112M.
- Lazard Asset Management's ten largest holdings make up 23% of its $79.1B portfolio in Q4 2020.
- Lazard Asset Management opened 445 new positions and closed 231 in Q4 2020.
- Lazard Asset Management's portfolio value rose 11% quarter-over-quarter to $79.1B.
Based on Lazard Asset Management's 13F filing for Q4 2020, filed 11 Feb 2021.